Getting your launch strategy right for today’s market access paradigm

Posted by Andre Moa on May 11, 2017 1:59:17 PM


As the challenges to pharmaceutical launch strategy, market access and success, become ever more imposing, no-one will prevail by throwing money and reps at the problem as companies did in the past. 

Read More

Topics: Pharma launch planning, launch challenges, launch readiness, pharma launch challenges, launch strategy

Pharma launch challenges will only get worse

Posted by Andre Moa on Apr 27, 2017 3:42:00 PM

A  healthy pharmaceutical industry runs on innovation. There is plenty of that left in the tank, judging by current market trends and product development pipelines. Pharma launch challenges, though, have never been tougher.

Read More

Topics: Pharma launch planning, launch challenges, launch readiness, pharma launch challenges

7 pharma trends for 2017 that will define the industry

Posted by Andre Moa on Jan 12, 2017 12:00:00 PM

With another turbulent year behind us, we look ahead to the pharma trends that we believe will shape the industry in 2017.

Read More

Topics: 2017 trends, Pharma launch planning, Pharma trends, Market access

8 pharma trends to keep top of mind in 2016

Posted by Andre Moa on Dec 16, 2015 9:44:00 AM


 

2016 Pharma Trends:  As the pharmaceutical industry enters 2016, rarely has the need for its products been greater and rarely has the industry been subject to such hostile scrutiny.

Read More

Topics: Pharma launch planning, Pharma trends, Market access, 2016 pharma trends

6 reasons your market access and launch efforts will suffer with Excel and SharePoint

Posted by Andre Moa on May 27, 2014 4:11:00 PM

 

Across the world, pharma companies of all sizes are still using a patchwork of non-specialised tools, typically Microsoft Excel, to organise their market access and launch efforts, with these files often shared across global and country teams in a SharePoint environment.

Read More

Topics: 2017 trends, Pharma launch planning, Pharma trends, Market access